Blog
About

1
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Stem cells hold key to tackling brain disease

      , , ,

      Impact

      Science Impact, Ltd.

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A rapidly ageing global society means a higher prevalence of neurodegenerative diseases. Looking at dementia, for example, the most common form of which is Alzheimer’s disease (AD), the World Health Organization estimates that worldwide, around 50 million people have dementia, and there are nearly 10 million new cases every year. And, it’s predicted that this number could rise to 150 million people by the year 2050. It’s clear that consistent and continued efforts to explore methods of prevention and treatments are required. Existing treatments include acetylcholinesterase (AChE) inhibitors, antibodies to Aβ and anti-inflammatory agents, but these are not without their drawbacks and limitations and new avenues must be explored. A group of Korean scientists believes that stem cells and regenerative medicine hold the key to alleviating the global burden of neurodegenerative diseases and this is where they are focusing their efforts. The innovative stem cell research being undertaken by Designed Cells Co., Ltd, which is based in Korea, performs important stem cell research geared towards improving life – enabling people to age gracefully and maintain wellbeing – and making treatments for neurodegenerative diseases available to all who need them. Professor James Yun-Bae Kim is CEO of the company and Dr Ehn-Kyoung Choi is Director of the company’s Central Research Institute. Through their work, the researchers are collaborating with numerous companies spanning different fields, the team is keen to work with global partners in any field to further expand their work to develop treatments for AD and more widely demonstrate the effectiveness of their research.

          Related collections

          Author and article information

          Journal
          Impact
          impact
          Science Impact, Ltd.
          2398-7073
          November 30 2020
          November 30 2020
          : 2020
          : 7
          : 67-69
          Article
          10.21820/23987073.2020.7.67
          © 2020

          This work is licensed under a Creative Commons Attribution 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

          Earth & Environmental sciences, Medicine, Computer science, Agriculture, Engineering

          Comments

          Comment on this article